Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The evolutionarily conserved miRNA-137 targets the neuropeptide hypocretin/orexin and modulates the wake to sleep ratio. | Proc Natl Acad Sci U S A | 2022 | 35452310 | PubTator, text mining | PubMed |
| Synergistic combination of PMBA and 5-fluorouracil (5-FU) in targeting mutant KRAS in 2D and 3D colorectal cancer cells. | Heliyon | 2022 | 35445157 | PubTator, text mining | PubMed |
| Treatment results for patients with squamous-cell carcinoma of the anus, a single institution retrospective analysis. | Radiat Oncol | 2022 | 35443730 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Epoxiconazole alters the histology and transcriptome of mouse liver in a transgenerational pattern. | Chem Biol Interact | 2022 | 35436446 | PubTator, text mining | PubMed |
| Clinical and biochemical footprints of inherited metabolic diseases. VIII. Neoplasias. | Mol Genet Metab | 2022 | 35422340 | PubTator, text mining | PubMed |
| Extracellular N6 -isopentenyladenosine (i6A) addition induces cotranscriptional i6A incorporation into ribosomal RNAs. | RNA | 2022 | 35414588 | PubTator, text mining | PubMed |
| Identification of distinct slow mode of reversible adaptation of pancreatic ductal adenocarcinoma to the prolonged acidic pH microenvironment. | J Exp Clin Cancer Res | 2022 | 35410237 | PubTator, text mining | PubMed |
| Prediction of Metabolic Profiles from Transcriptomics Data in Human Cancer Cell Lines. | Int J Mol Sci | 2022 | 35409231 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor Progression. | Cancers (Basel) | 2022 | 35406386 | PubTator, text mining | PubMed |
| Structural Variation at a Disease Mutation Hotspot: Strategies to Investigate Gene Regulation and the 3D Genome. | Front Genet | 2022 | 35401663 | PubTator, text mining | PubMed |
| Capecitabine-Induced Enterocolitis. | Cureus | 2022 | 35399470 | PubTator, text mining | PubMed |
| Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study. | Clin Pharmacol Ther | 2022 | 35397172 | PubTator, text mining | PubMed |
| Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task. | Front Endocrinol (Lausanne) | 2022 | 35388297 | PubTator, text mining | PubMed |
| Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells. | BMC Cancer | 2022 | 35379199 | PubTator, text mining | PubMed |
| Identification of lncRNAs and Their Regulatory Relationships with mRNAs in Response to Cryptococcus neoformans Infection of THP-1 Cells. | Biomed Res Int | 2022 | 35378790 | PubTator, text mining | PubMed |
| Correction: Hypoxia Drives Dihydropyrimidine Dehydrogenase Expression in Macrophages and Confers Chemoresistance in Colorectal Cancer. | Cancer Res | 2022 | 35373293 | PubTator, text mining | PubMed |
FIRE-9 - PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer. | BMC Cancer | 2022 | 35366831 | PubTator, text mining | PubMed |
| Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data. | Pharmacogenomics J | 2022 | 35361994 | PubTator, text mining | PubMed |
| Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions. | Front Pain Res (Lausanne) | 2022 | 35360655 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=46